AI based models achieved an accuracy rate of 86% for detecting ovarian cancer, compared to 82% for human experts.

In a new study led by researchers at Karolinska Institutet in Sweden, AI models did a better job of detecting ovarian cancer ...

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...

FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat ...

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...

Uncover shocking connections between endometriosis and ovarian cancer risk, with key insights on prevention and monitoring ...

Artificial intelligence (AI)-based models developed by a team of international researchers were able to identify ovarian ...

When we got back from the beach, fall was in the air, and we both were back in the reality of doctor appointments, CT scans, ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The Minnesota Department of Health (MDH) says about 3,850 women in Minnesota are living with an ovarian cancer diagnosis and ...

AI can outperform human doctors when it comes to identifying ovarian cancer from ultrasound images. A new study published in ...

The top 5 ovarian cancer articles of 2024 covered topics such as the impact of air pollution on ovarian cancer risk, treatment strategies for patients with liver metastases, and the benefits of early ...